SCHEMBL13724862

SCHEMBL13724862

O=C(Oc1ccc(-c2ccccc2)cc1)c1cc(Cl)cc2c1NC(C(=O)O)C1CC=CC21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN7 P35236 14/20 0.76
▸ TDP1 Q9NUW8 4/20 0.60
▸ POLB P06746 3/20 0.60
▸ BLM P54132 3/20 0.60
▸ L3MBTL1 Q9Y468 3/20 0.60
▸ NR4A1 P22736 3/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ PLA2G1B P04054 1/20 0.60
▸ ATG4B Q9Y4P1 1/20 0.60
▸ CDC25B P30305 2/20 0.52
▸ HSPA1A P0DMV8 8/20 0.52
▸ HSPA8 P11142 5/20 0.52
▸ GAPDH P04406 4/20 0.52
▸ CD44 P16070 1/20 0.50
▸ MSN P26038 1/20 0.50
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ THRB P10828 2/20 0.47
▸ RECQL P46063 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13725206 0.86 PTPN7 (0.87) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13726154 0.82 PTPN7 (0.81) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13725695 0.82 PTPN7 (0.74) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13725616 0.81 PTPN7 (0.89) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13725254 0.80 PTPN7 (0.84) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13726141 0.80 PTPN7 (0.87) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13725212 0.80 PTPN7 (0.88) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13725184 0.79 PTPN7 (0.75) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13724823 0.79 PTPN7 (0.85) PTPN7TDP1POLBBLML3MBTL1
SCHEMBL13725608 0.78 PTPN7 (0.82) PTPN7TDP1POLBBLML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
WO-2009073550-A2 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS NISCH, NDUFS3, SDHA PTPN7 3898/4885TDP1 3729/4885POLB 1343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback